Highlight Therapeutics, S.L.

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com

Having just seen portfolio company Sanifit Therapeutics S.A. snapped up by Vifor Pharma Group , constituting the largest acquisition in the Spanish biotech sector over the past few years, Pablo Ci

Spain's Highlight Therapeutics, S.L. has emerged as one of the leading players to tackle the problem of resistance to current checkpoint inhibitor therapy, with its lead candidate BO-112 moving into

"The coming year will be remembered for the epic alteration to our society." These words from Pam Contag , CEO and co-founder of BioEclipse Therapeutics, Inc. , encapsulate the enormity of COVID-19'